PSMO 39th Annual Convention
PSMO at the HEART ( Healthcare, Education, Access, Research, Transformation) of the Filipino patients' cancer care journey.
PSMO's 39th Annual Convention Highlights
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
Same Day Edit Video of the Day 1 Highlights during PSMO's 39th Annual Convention with the theme "PSMO at the HEART of the Filipino patients' cancer care journey" held last October 7-10, 2025 at the EDSA Shangri-La Hotel
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
Same Day Edit Video of the Day 2 Highlights during PSMO's 39th Annual Convention with the theme "PSMO at the HEART of the Filipino patients' cancer care journey" held last October 7-10, 2025 at the EDSA Shangri-La Hotel.
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
Same Day Edit Video of the Day 3 Highlights during PSMO's 39th Annual Convention with the theme "PSMO at the HEART of the Filipino patients' cancer care journey" held last October 7-10, 2025 at the EDSA Shangri-La Hotel.
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
PSMO President Dr. Chita Matunog reinforces the societyβs commitment to advancing cancer research, strengthening data, and championing patient advocacy, shaping a future where every Filipino with cancer receives better care.
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
Drs. Mary Claire V. Soliman, Albert Domingo, Jacinto Blas V. Mantaring III, Rubi K. Li, & Christopher MuΓ±oz explore breaking barriers in cancer care through improved access & advocacy, discussing Universal Health Care implementation, health financing systems, HTA priority-setting mechanisms, & collaborative multistakeholder approaches.
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
Drs. Arthur Gregory Lui, Choo Su Pin, and Sun Young Rha bridge global and Asian perspectives on gastric cancer, exploring Pan-Asian guidelines adaptation with focus on PET/CT sensitivity, diagnostic laparoscopy recommendations, multidisciplinary team approaches, and targeted treatment strategies for metastatic disease.
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
Drs. Jasmin V. Reyes-Igama, Francisco P. Tranquilino, Atty. Lee Edson P. Yarcia, and Rosario Angeles Tan-Alora address ethical and legal dilemmas in oncology practice, emphasizing patient-centered care, ethical decision-making through reflection and practice, and the importance of truth, justice, and compassion in navigating complex situations.
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
Drs. Esther Rhadamanthine Ganzon & Irisyl Real discuss clinical pearls in gynecologic oncology, covering standards and innovations in managing endometrial, cervical, and ovarian cancers, including risk stratification, molecular profiling for precision treatment, & surgical approaches tailored to patient needs.
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
Philippine breast cancer experts Drs. Ellie May D. Villegas, Joseff Karl U. Fernandez, Arthur Gregory A. Lui, and Ma. Luisa A. Tiambeng share local perspectives on HER2+ breast cancer management, discussing neoadjuvant dual HER2 blockade benefits, prognostic information for treatment planning, and standard adjuvant approaches for node-positive cases.
β
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
Dr. Alfonso G. NuΓ±ez III shares the Philippine Cancer Center's vision to become the nation's leading cancer care institution by 2040, highlighting initiatives in research, patient care, and the upcoming specialty hospital in Quezon City.
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
Drs. Annielyn Ong-Cornel & Daphne Ang explore blood-based multi-cancer early detection (MCED), discussing how liquid biopsy technology shows promise in detecting multiple cancers while addressing challenges in cost & accessibility.
ππππ's 39π΅π© ππ―π―πΆπ’π ππ°π―π·π¦π―π΅πͺπ°π― ππͺπ¨π©ππͺπ¨π©π΅
Drs. Henri Cartier Co, Dennis Sacdalan, and Marie Dione Sacdalan discuss challenging rectal cancer cases, covering surgical approaches based on tumor stage and recurrence risk, the impact of EMVI on treatment decisions, and management of oligometastatic liver disease.